Nadmierna ilość śluzu w drogach oddechowych jest cechą wielu ciężkich chorób układu
oddechowego, w tym przewlekłej obturacyjnej choroby płuc (POChP), mukowiscydozy i …

This study was designed to examine the efficacy and tolerability of ambroxol (Ambrosol) on
the symptomatology of chronic bronchitis among in-and out-patients. Seventy patients were …

Background Ambroxol has been established for decades in the treatment of acute and
chronic respiratory diseases. In 2015, the European Medicines Agency reassessed the …

OBJECTIVE: To review the efficacy and safety of ambroxol for treatment of bronchiofitis.
METHODS: Random controlled trials (RCTs), systematic review (SR), and meta-analysis of …

Background Ambroxol, trans-4-/(2-amino-3, 5-dibromobenzyl) amino/cyclohexanol
hydrochloride, a drug used to increase surfactant secretion in the lungs, has been reported …

Background: Belonging to the group of expectorants, ambroxol is an active substance with a
long history that influences parameters considered to be the basis for the physiological …

Many years of experience in the use of ambroxol is based on its ability to regulate the basic
mechanisms of physiological production and transport of bronchial mucus. The main …

Asthma (Greek word that means" breathlessness" or" open-mouth breath") is a chronic
inflammatory disorder of the airways, with extensive infiltration of the airway lumen and wall …

It was a randomised, double-blind, placebo controlled comparative study of the clinical
symptoms and chosen parameters of ventilation of inhaled ambroxol in patients hospitalized …

Introduction: Ambroxol is a widely used secretolytic and mucoactive over-the-counter agent
primarily used to treat respiratory diseases associated with viscid mucus. Following post …